发明名称 |
Cellular Activation Insulin Therapy |
摘要 |
Diabetic and other patients are treated using an aggressive form of Pulsed Insulin Therapy in which a pre-treatment blood sugar level in the patient of at least 250-300 mg/dL, and the patient is treated with at least first and second cycles, each cycle comprising (1) pulsing a recombinant human insulin to the patient in concentrations of more than 10% to achieve a target intra-treatment blood sugar level (BSL) swing of more than 100 mg/dL, and (2) raising the blood sugar level to at least 250-300 mg/dL.
|
申请公布号 |
US2011144011(A1) |
申请公布日期 |
2011.06.16 |
申请号 |
US20100968120 |
申请日期 |
2010.12.14 |
申请人 |
MCCARTHY MICHAEL;ROSE MARC |
发明人 |
MCCARTHY MICHAEL;ROSE MARC |
分类号 |
A61K38/28;A61P3/10;A61P17/02;A61P29/00;A61P37/06 |
主分类号 |
A61K38/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|